We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Finance Committee Wants Answers From Former GSK Exec
Senate Finance Committee Wants Answers From Former GSK Exec
November 30, 2007
Two senior members of the Senate are seeking an interview with Tadataka Yamada, the former chairman of R&D for GlaxoSmithKline (GSK), to discuss his role in the alleged intimidation of a researcher who raised concerns in 1999 about cardiovascular risks associated with Avandia.